These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13161623)

  • 21. [Letter: Leukemia following treatment with hydantoin].
    Endtz LJ; Leeksma CH; Kerkhofs H; Mulder OG; Mosmans FA; Meinardi H
    Munch Med Wochenschr; 1973 Oct; 115(42):1859. PubMed ID: 4520458
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral changes due to hydantoin].
    Nejad RH
    J Dent Sch Natl Univ Iran; 1977 Jan; 8(2):7-15, 77. PubMed ID: 267142
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of orally administered hydantoin in the prevention of arrhythmia and sudden death in patients with myocardial infarct].
    Kedra M; Rymar B; Trojnar R; Jach A; Staśkiewicz J; Bielak J
    Pol Tyg Lek; 1977 Jan; 32(2):45-8. PubMed ID: 834632
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hydantoin derivatives and malignancies of the haemopoietic system].
    Bichel J
    Folia Clin Int (Barc); 1976 Oct; 26(10):420-1. PubMed ID: 1036724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Stevens-Johnson syndrome following hydantoin administration in the course of myocardial infarct].
    Woyda J
    Wiad Lek; 1970 Mar; 23(5):395-8. PubMed ID: 5437073
    [No Abstract]   [Full Text] [Related]  

  • 26. The fetal hydantoin syndrome.
    Oğuz A; Sezgin I; Gökalp A; Gültekin A
    Mater Med Pol; 1991; 23(4):308-11. PubMed ID: 1842240
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sperm analysis of patients after long term use of hydantoin].
    Schramm P; Seyfeddinipur N
    Andrologia; 1980; 12(1):97-101. PubMed ID: 6769360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The fetal hydantoin syndrome (author's transl)].
    Elefant E
    Klin Padiatr; 1978 May; 190(3):307-12. PubMed ID: 566353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fetal diseases due to hydantoin. Description of a case].
    Nicoletti I; Mariotti G; Filipponi P; Serena Lungarotti M
    Minerva Pediatr; 1980 Jan; 32(1):61-4. PubMed ID: 6789050
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of neuralgiform maxillofacial pain with hydantoin (Phenhydan)].
    Geiger SA; Peuten M
    Dtsch Zahnarztl Z; 1990 Jan; 45(1):43-4. PubMed ID: 2257802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphadenopathy resulting from long-term use of hydantoin.
    Szegedi G; Krasznai G; Sorszegi P; Szabó G
    Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hydantoin fetal syndrome].
    Dang PM; Dufetelle B; Bonnetblanc JM
    Ann Dermatol Venereol; 1993; 120(9):621-4. PubMed ID: 8161117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal hemorrhage secondary to thrombocytopenia: an occasional effect of prenatal hydantoin exposure.
    Page TE; Hoyme HE; Markarian M; Jones KL
    Birth Defects Orig Artic Ser; 1982; 18(3 Pt A):47-54. PubMed ID: 7126797
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences on the use of medicinal plant extracts for traumatic and inflammatory swelling of the soft tissue].
    Jonas FJ
    Dtsch Med J; 1966 Oct; 17(19):572-3. PubMed ID: 5979898
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic lupus erythematosus caused by hydantoin preparations.
    Szegedi G; Petrányi G
    Ann Immunol Hung; 1972; 16(0):433-44. PubMed ID: 4607152
    [No Abstract]   [Full Text] [Related]  

  • 36. [Vegetative dystrophic epidermolysis bullosa. Urogenital manifestations and treatment with hydantoin].
    Woscoff A; Paz A; Abulafia J; Jaimovich L; Grinspan D
    Med Cutan Ibero Lat Am; 1984; 12(2):129-35. PubMed ID: 6374321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complications in the central nervous system in the treatment of epileptics with hydantoins (author's transl)].
    Gottwald W
    MMW Munch Med Wochenschr; 1975 Dec; 117(51-52):2005-10. PubMed ID: 818510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modifications of phosphocalcic metabolism in patients treated with anticonvulsivants (author's transl)].
    Palencia R; Blanco A; Blanco S
    An Esp Pediatr; 1975; 8(6):626-9. PubMed ID: 1211691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new synergistic compound in the therapy of epilepsy].
    DE SANCTIS T
    Riv Sper Freniatr Med Leg Alien Ment; 1954 Dec; 78(4):817-30. PubMed ID: 14372859
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reticular hyperplasia following hydantoin derivatives].
    Wasik F; Domanasiewicz M; Gasior B
    Hautarzt; 1975 May; 26(5):273-5. PubMed ID: 125251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.